Molina Healthcare — Feb 5, 2026 release

Reports Fourth Quarter and Year-End 2025 Financial Results Page 3 February 5, 2026 segment is expected to be partially offset by growth from the new Florida CMS contract in Medicaid and higher premium in Medicare. The Company expects its full year 2026 GAAP earnings to be at least $3.20 per diluted share and its full year 2026 adjusted earnings to be at least $5.00 per diluted share. The guidance is burdened by $2.50 per diluted share, which includes $1.50 per diluted share due to implementation of the new Florida CMS Medicaid contract and $1.00 per diluted share due to underperformance in the traditional Medicare Advantage Part D product. The Company has determined the MAPD product with approximately $1 billion in annual premium does not align with its strategic shift to focus exclusively on its $5 billion dual eligible business in Medicare. The Company will exit the MAPD product for 2027. Guidance metrics are summarized below: Full Year 2026 Guidance Premium Revenue $42.2B Total Revenue $44.5B GAAP Net Income $164M Adjusted Net Income $256M GAAP EPS – Diluted ≥ $3.20 Adjusted EPS – Diluted ≥ $ 5.00 Diluted weighted average shares 51.1M Year End Total Membership 5.1M Medicaid 4.6M Medicare 230K Marketplace 220K MCR 92.6% Medicaid 92.9% Medicare 94.0% Marketplace 85.5% GAAP G&A Ratio 6.5% Adjusted G&A Ratio 6.4% Effective Tax Rate 30.0% GAAP Pre-tax Margin 0.5% Adjusted Pre-tax Margin 0.8% See the Reconciliations of Unaudited Non-GAAP Financial Measures at the end of this release.